Outcomes and Risk Factors for Liver Transplantation Using Significant Fibrotic Grafts
NCT ID: NCT07101718
Last Updated: 2025-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
25419 participants
OBSERVATIONAL
2024-07-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multiomics Study of Fibrosis Factors After Liver Transplantation and Exploration of Fibrosis Methylation Biomarkers
NCT05926778
Impact of Age and BMI on Liver Transplant Outcomes
NCT04853641
Cytokeratin 18 Non-invasive Biomarker for Rejection in Liver Transplant Patients
NCT06153641
Radiomics-based Non-invasive Classifier Research for HCC-related Liver Transplantation
NCT03981848
Orthotopic Liver Transplantation Using a Living Donor
NCT00152607
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No fibrotic
Liver transplant recipient receiving no fibrotic liver grafts.
No intervention
No intervention
Mild fibrotic
Liver transplant recipient receiving mild fibrotic liver grafts.
No intervention
No intervention
Significant
Liver transplant recipient receiving significant fibrotic liver grafts.
No intervention
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. re-transplantation cases
3. multiorgan transplant cases, reduced-size or split LT cases
4. lacking follow-up records or graft biopsy records
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiao Xu
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhejiang University school of Medicine
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CT-2025-ZJU-OBS07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.